![Huma Qamar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 6 122 $ au 31/05/2026
Huma Qamar formerly worked at Ocugen, Inc., as Chief Medical Officer from 2024 to 2026, Quantum BioPharma Ltd., as Head-Research & Development, and Medicus Pharma Ltd., as Chief Scientific Officer from 2023 to 2024.
Dr. Qamar received her doctorate degree from Army Medical College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 4 436 ( 0% ) | 6 122 $ | 31/05/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| OCUGEN, INC. | Directeur Technique/Scientifique/R&D | 08/05/2026 |
| QUANTUM BIOPHARMA LTD. | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Army Medical College
 Army Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FSD Pharma, Inc.
 FSD Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurodegenerative, inflammatory and metabolic disorders | Health Technology |
Ocugen, Inc.
 Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
